Veru (VERU) Change in Inventory (2015 - 2024)
Veru (VERU) posted quarterly Change in Inventory of -$863928.0 for Q4 2024, down 528.08% year-over-year from $201814.0 in Q1 2024, and down 73.69% quarter-over-quarter from -$497404.0 in Q3 2024.
Veru (VERU) Change in Inventory (2015 - 2024) Analysis & Trends
Veru (VERU) has reported Change in Inventory for 10 consecutive years, with -$863928.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Change in Inventory fell 528.08% year-over-year to -$863928.0; the TTM figure through Sep 2025 stood at -$863928.0 (up 12.39% YoY), while the FY2025 annual figure was -$863928.0, up 12.39% from the prior year.
- Change in Inventory retreated to -$863928.0 in Q4 2024 per VERU's latest filing, from -$497404.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.6 million in Q1 2022 and bottomed at -$1.3 million in Q1 2024.
- Historically, Change in Inventory has averaged $114165.6 across 5 years, with a median of $43758.0 in 2020.
- Annual changes were most pronounced in 2021 — Change in Inventory plunged 2392.99% — and 2024, when it surged 843.1%.
- Veru's Change in Inventory stood at -$29088.0 in 2020, then slumped by 2392.99% to -$725161.0 in 2021, then jumped by 116.08% to $116604.0 in 2022, then surged by 73.08% to $201814.0 in 2023, then tumbled by 528.08% to -$863928.0 in 2024.
- Business Quant data shows VERU's Change in Inventory at -$863928.0 in Q4 2024, -$497404.0 in Q3 2024, and $624749.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -863,928.00 |
| Dec 31, 2024 | -863,928.00 |
| Sep 30, 2024 | -497,404.00 |
| Sep 30, 2024 | -497,404.00 |
| Jun 30, 2024 | 624,749.00 |
| Jun 30, 2024 | 624,749.00 |
| Mar 31, 2024 | -1.32 Mn |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | 201,814.00 |
| Dec 31, 2023 | 201,814.00 |
| Sep 30, 2023 | 197,060.00 |
| Sep 30, 2023 | 197,060.00 |
| Jun 30, 2023 | -84,073.00 |
| Jun 30, 2023 | -84,073.00 |
| Mar 31, 2023 | -878,219.00 |
| Mar 31, 2023 | -878,219.00 |
| Dec 31, 2022 | 116,604.00 |
| Dec 31, 2022 | 116,604.00 |
| Sep 30, 2022 | 910,333.00 |
| Sep 30, 2022 | 910,333.00 |